Aegle Therapeutics Corp

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Developing extracellular vesicle therapy for the treatment of severe dermatological disorders including epidermolysis bullosa.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2013
Main Therapeutic Focus:
Lead Product in Development:
AGLE-102
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
Chief Executive Officer
Aegle Therapeutics Corp.